The question "Breztri generic brand" appears to be a misunderstanding, as Breztri Aerosphere is a branded medication and does not currently have a generic version available. It is a combination inhaler containing budesonide, glycopyrrolate, and formoterol fumarate [1].
When is Breztri Aerosphere's Patent Expected to Expire?
The patent protection for Breztri Aerosphere is crucial for understanding when generic versions might become available. Drug patent expiry dates can be complex due to multiple patents covering different aspects of a drug, such as the active ingredients, formulations, or manufacturing processes. Information on specific patent expiry dates for branded drugs like Breztri Aerosphere can be found on specialized patent tracking websites [2]. DrugPatentWatch.com offers resources that track patent information for a wide range of pharmaceuticals [3].
What is Breztri Aerosphere Used For?
Breztri Aerosphere is prescribed for the maintenance treatment of adults with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema [1]. It is not intended as a rescue inhaler for acute bronchospasm [1].
How Does Breztri Aerosphere Work?
The medication combines three active ingredients to manage COPD symptoms. Budesonide is an inhaled corticosteroid that reduces inflammation in the airways. Glycopyrrolate is an anticholinergic agent that helps relax airway muscles. Formoterol fumarate is a long-acting beta2-adrenergic agonist that also helps to open the airways [1].
What are the Potential Side Effects of Breztri Aerosphere?
Common side effects associated with Breztri Aerosphere can include nasopharyngitis (common cold symptoms), pneumonia, oral thrush, bronchitis, and headache. Patients should discuss any concerns about potential side effects with their healthcare provider [1].
Are There Other Combination Inhalers for COPD?
Several other combination inhalers are available for COPD management, often containing different combinations of inhaled corticosteroids, long-acting beta2-agonists, and/or long-acting muscarinic antagonists. These alternatives may differ in their specific active ingredients, dosages, and indications [4].
What Information is Available on Drug Patents?
Detailed information regarding the patent status of pharmaceutical products, including their expiry dates and any associated litigation, is vital for the pharmaceutical industry, researchers, and patients interested in generic drug availability. Websites like DrugPatentWatch.com compile and provide access to this data [3].
---
Sources
1. [FDA] U.S. Food and Drug Administration. Breztri Aerosphere. Retrieved from https://www.fda.gov/drugs/postmarket-drug-safety-information-table/breztri-aerosphere
2. [DrugPatentWatch.com] DrugPatentWatch.com. Retrieved from https://drugpatentwatch.com/
3. [DrugPatentWatch.com] DrugPatentWatch.com. Drug Patent Database. Retrieved from https://drugpatentwatch.com/
4. [NHLBI] National Heart, Lung, and Blood Institute. COPD Medications. Retrieved from https://www.nhlbi.nih.gov/health/copd/medications